NA
PFE icon

Nottingham Advisors’s Pfizer PFE Stock Holding History

Nottingham Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,701
Closed -$241K – 152
2022
Q4 		$241K Buy
+4,701
New +$225K 0.03% 133
2017
Q4 		– Sell
-6,602
Closed -$224K – 110
2017
Q3 		$224K Buy
+6,602
New +$212K 0.03% 102

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nottingham Advisors's PFE Position: Q1 2023 in Review

Nottingham Advisors sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,701 shares — an estimated $241K sold.

Nottingham Advisors first reported a position in PFE in Q3 2017 and held it in 2 quarters. The position peaked at $241K in Q4 2022. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Nottingham Advisors reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Nottingham Advisors sold 4,701 Pfizer shares in Q1 2023, an estimated $241K.
  • Nottingham Advisors first reported a position in Pfizer in Q3 2017 and held it in 2 quarters.
  • Nottingham Advisors's Pfizer position peaked at $241K in Q4 2022.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Nottingham Advisors's 13F filing for Q1 2023, filed 12 May 2023.